메뉴 건너뛰기
Clinical and Experimental Dermatology
Volumn 31, Issue 6, 2006, Pages 823-824
Treatment of chronic erythema nodosum with infliximab [7]
Author keywords

[No Author keywords available]
Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CHIMERIC ANTIBODY; DAPSONE; HEMOGLOBIN; HYDROCORTISONE; HYDROXYCHLOROQUINE; INFLIXIMAB; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;
EID: 33749844237     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02221.x     Document Type: Letter
Times cited : (35)
References (6)
  • 1
    • 0033761188 scopus 로고    scopus 로고
    • Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease
    • Kugathasan S, Werlin SL, Martinez A et al. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. Am J Gastroenterol 2000; 95: 3189-94.
    • (2000) Am J Gastroenterol , vol.95 , pp. 3189-3194
    • Kugathasan, S.1    Werlin, S.L.2    Martinez, A.3
  • 2
    • 23944510297 scopus 로고    scopus 로고
    • The effect of infliximab on extraintestinal manifestations of Crohn's disease
    • Kaufman I, Caspi D, Yeshurun D et al. The effect of infliximab on extraintestinal manifestations of Crohn's disease. Rheumatol Int 2005; 25: 406-10.
    • (2005) Rheumatol Int , vol.25 , pp. 406-410
    • Kaufman, I.1    Caspi, D.2    Yeshurun, D.3
  • 3
    • 26944454852 scopus 로고    scopus 로고
    • Regression of Sweet's syndrome associated with Crohn's disease after anti-tumour necrosis factor therapy
    • Rahier JF, Lion L, Dewit O, Lambert M. Regression of Sweet's syndrome associated with Crohn's disease after anti-tumour necrosis factor therapy. Acta Gastroenterol Belg 2005; 68: 376-9.
    • (2005) Acta Gastroenterol Belg , vol.68 , pp. 376-379
    • Rahier, J.F.1    Lion, L.2    Dewit, O.3    Lambert, M.4
  • 4
    • 0035012569 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha promoter polymorphism in erythema nodosum
    • Labunski S, Posern G, Ludwig S et al. Tumor necrosis factor-alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 2001; 81: 18-21.
    • (2001) Acta Derm Venereol , vol.81 , pp. 18-21
    • Labunski, S.1    Posern, G.2    Ludwig, S.3
  • 5
    • 0030887808 scopus 로고    scopus 로고
    • Elevated Th1 cytokine mRNA in skin biopsies and peripheral circulation in patients with erythema nodosum
    • Llorente L, Richaud-Patin Y, Alvarado C et al. Elevated Th1 cytokine mRNA in skin biopsies and peripheral circulation in patients with erythema nodosum. Eur Cytokine Netw 1997; 8: 67-71.
    • (1997) Eur Cytokine Netw , vol.8 , pp. 67-71
    • Llorente, L.1    Richaud-Patin, Y.2    Alvarado, C.3
  • 6
    • 1542329560 scopus 로고    scopus 로고
    • Failure of infliximab treatment and occurrence of erythema nodosum during therapy in two patients with Behcet's disease
    • Yucel AE, Kart-Koseoglu H, Akova YA et al. Failure of infliximab treatment and occurrence of erythema nodosum during therapy in two patients with Behcet's disease. Rheumatology (Oxford) 2004; 43: 394-6.
    • (2004) Rheumatology (Oxford) , vol.43 , pp. 394-396
    • Yucel, A.E.1    Kart-Koseoglu, H.2    Akova, Y.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.